Unicycive Therapeutics, Inc. (UNCY) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$6.5
Day's range
$7.11

Unicycive Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 1.41 M $6.63 M   3,836.67% 5.25%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 1.40 M $6.57 M   49.22% 5.21%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.07 M $5.03 M   32.05% 3.98%
OCTAGON CAPITAL ADVISORS LP 08/14/2026 1.00 M $4.69 M   0.00% 3.72%
DIADEMA PARTNERS LP 08/14/2026 792.60 K $3.72 M   100.00% 2.94%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 564.02 K $2.65 M   176.83% 2.10%
VIVO CAPITAL, LLC 08/14/2026 550.00 K $2.58 M   -69.27% 2.04%
MARSHALL WACE, LLP 08/13/2026 547.86 K $2.57 M   253.60% 2.04%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 473.56 K $2.22 M   0.00% 1.76%
STATE STREET CORP 08/07/2026 450.16 K $2.11 M   462.51% 1.67%
CAPTION MANAGEMENT, LLC 08/14/2026 420.00 K $1.97 M   100.00% 1.56%
DIAMETRIC CAPITAL, LP 08/14/2026 374.13 K $1.75 M   365.56% 1.39%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 334.80 K $1.57 M   348.79% 1.24%
J. GOLDMAN & CO LP 08/14/2026 327.35 K $1.54 M   100.00% 1.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 314.80 K $1.48 M   -2.99% 1.17%
DIADEMA PARTNERS LP 08/14/2026 303.68 K $1.42 M   186.26% 1.13%
MILLENNIUM MANAGEMENT LLC 08/14/2026 271.46 K $1.27 M   -80.60% 1.01%
DAUNTLESS INVESTMENT GROUP, LLC 08/13/2026 214.00 K $1.00 M   45.49% 0.80%
CITIGROUP INC 08/03/2026 182.65 K $856.65 K   18,265,300.00% 0.68%
NORTHERN TRUST CORP 08/13/2026 181.93 K $853.25 K   406.25% 0.68%
JANE STREET GROUP, LLC 08/14/2026 178.90 K $839.04 K   318.97% 0.66%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 169.20 K $793.53 K   100.00% 0.63%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 160.04 K $750.58 K   -19.67% 0.59%
JUMP FINANCIAL, LLC 08/13/2026 153.00 K $717.57 K   100.00% 0.57%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 148.97 K $698.65 K   47.38% 0.55%
CITADEL ADVISORS LLC 09/02/2026 147.70 K $692.71 K   79.03% 0.55%
GOLDMAN SACHS GROUP INC 08/14/2026 145.30 K $681.48 K   436.32% 0.54%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 143.05 K $678.02 K   0.00% 0.53%
CAPTION MANAGEMENT, LLC 08/14/2026 110.00 K $515.90 K   100.00% 0.41%
MORGAN STANLEY 08/13/2026 109.65 K $514.24 K   -41.73% 0.41%
SEVEN FLEET CAPITAL MANAGEMENT LP 08/17/2026 103.40 K $521.14 K   85.64% 0.38%
LOS ANGELES CAPITAL MANAGEMENT LLC 08/13/2026 95.02 K $445.64 K   100.00% 0.35%
CITADEL ADVISORS LLC 09/02/2026 92.50 K $433.83 K   264.17% 0.34%
PERSISTENT ASSET PARTNERS LTD 08/07/2026 90.17 K $422.87 K   236.10% 0.34%
SCIENTECH RESEARCH LLC 08/14/2026 74.49 K $349.36 K   100.00% 0.28%
UBS GROUP AG 08/13/2026 69.38 K $325.38 K   256.80% 0.26%
CITADEL ADVISORS LLC 09/02/2026 61.17 K $286.88 K   -74.17% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 54.84 K $257.21 K   100.00% 0.20%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 54.84 K $257.21 K   100.00% 0.20%
BANK OF NEW YORK MELLON CORP 08/06/2026 52.81 K $247.67 K   100.00% 0.20%
CANTOR FITZGERALD, L. P. 08/19/2026 50.00 K $234.50 K   -33.33% 0.19%
NUVEEN, LLC 08/11/2026 47.82 K $224.28 K   100.00% 0.18%
SIMPLEX TRADING, LLC 08/12/2026 40.42 K $189.58 K   594.54% 0.15%
BARCLAYS PLC 08/14/2026 39.00 K $182.92 K   -22.00% 0.14%
BANK OF AMERICA CORP /DE/ 08/14/2026 31.64 K $148.38 K   7.14% 0.12%
JANE STREET GROUP, LLC 08/14/2026 29.50 K $138.36 K   -28.40% 0.11%
RHUMBLINE ADVISERS 08/12/2026 29.29 K $137.35 K   100.00% 0.11%
PRELUDE CAPITAL MANAGEMENT, LLC 08/14/2026 27.72 K $130.00 K   126.63% 0.10%
DEUTSCHE BANK AG\ 08/07/2026 24.27 K $113.85 K   100.00% 0.09%
WELLS FARGO & COMPANY/MN 08/14/2026 22.07 K $103.50 K   100.00% 0.08%

Unicycive Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 92 institutional investors and hedge funds held shares of Unicycive Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 1.41 M

Nantahala Capital Management, LLC: 1.4 M

VANGUARD CAPITAL MANAGEMENT LLC: 1.07 M

Octagon Capital Advisors LP: 1,000,000

GEODE CAPITAL MANAGEMENT, LLC: 564,019

Vivo Capital, LLC: 550,000

43.34% of Unicycive Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 12.55 M shares in the last 24 months. This purchase volume represents approximately $88.48 M in transactions.